Results 81 to 90 of about 669,583 (341)

Clinical progress note: Hepatitis A virus

open access: yesJournal of Hospital Medicine, EarlyView.
Abstract Despite a decline in hepatitis A virus (HAV) incidence following vaccine introduction, HAV remains a public health concern in the United States. Recent multi‐state outbreaks have demonstrated that HAV can re‐emerge and highlight inequities in vaccine coverage or access, outbreak response, and in those with social or health risk factors ...
James M. McCluskey III   +2 more
wiley   +1 more source

Rifaximin in the treatment of hepatic encephalopathy

open access: yesHepatic Medicine: Evidence and Research, 2011
Maddalena Diana Iadevaia, Anna Del Prete, Claudia Cesaro, Laura Gaeta, Claudio Zulli, Carmelina LoguercioDepartment of Internistica Clinica e Sperimentale, F Magrassi e A Lanzara, Hepatogastroenterology Unit, Second University of Naples, Naples ...
Iadevaia MD   +5 more
doaj  

Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi‐centre cohort

open access: yesAlimentary Pharmacology and Therapeutics, 2019
Hepatic encephalopathy (HE) can adversely affect outcomes in both in‐patients and out‐patients with cirrhosis.
J. Bajaj   +14 more
semanticscholar   +1 more source

Pediatric liver transplant outcomes: A comparative analysis of steatotic donor grafts

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Hepatic steatosis impacts the quality of grafts, affecting transplant outcomes. Rising obesity rates and subsequent donor graft steatosis further influence the organ shortage crisis in pediatric liver transplantation (LT). Our study aimed to evaluate how donor steatosis modulates the outcomes of pediatric LT. Methods We analyzed the
Ahmad Anouti   +5 more
wiley   +1 more source

Minimal hepatic encephalopathy - from cirrhosis to neurological disorders

open access: yesJournal of Education, Health and Sport
Introduction and aim Minimal hepatic encephalopathy (MHE) is a subtle but significant brain dysfunction resulting from chronic liver damage, with symptoms that can be difficult to detect.
Jakub Jarmołowicz   +5 more
doaj   +1 more source

A Head CT is Unnecessary in the Initial Evaluation of A Cirrhotic Patient with Recurrent Hepatic Encephalopathy

open access: yesAnnals of Hepatology, 2018
Introduction and aim. The evaluation to determine the cause of hepatic encephalopathy consists primarily of laboratory testing to rule out infections and metabolic causes.
Sumit Kumar   +4 more
doaj   +1 more source

Decline in gut motility of cerebral palsy patients after a triggering event: A discussion on invasive versus conservative management

open access: yesJPGN Reports, EarlyView.
Abstract Objectives Patients with cerebral palsy (CP) often have gastrointestinal dysmotility. An inciting event, such as infection, may lead to progressive decline in bowel motility and episodes of acute pediatric intestinal pseudo‐obstruction (PIPO).
Zoe Saenz   +4 more
wiley   +1 more source

Melatonin Levels in Serum and Ascitic Fluid of Patients with Hepatic Encephalopathy

open access: yesGastroenterology Research and Practice, 2012
Cirrhotic patients exhibit disturbed melatonin homeostasis, which may lead to sleep disturbances, but an influence on the hepatic encephalopathy has not been elucidated. Aim.
Cezary Chojnacki   +4 more
doaj   +1 more source

Serum natremia affects health-related quality of life in patients with liver cirrhosis: a prospective, single centre study

open access: yesAnnals of Hepatology, 2013
Introduction. Hyponatremia is associated with high mortality and predicts hepatic encephalopathy but its effect on health-related quality of life remains to be established.Material and methods.
Ewa Wunsch   +5 more
doaj   +1 more source

Comparing efficacy of Rifaximin plus Lactulose vs. Lactulose alone in treating Hepatic Encephalopathy

open access: yesJournal of Rawalpindi Medical College, 2020
Background: Hepatic Encephalopathy is a syndrome observed in patients with liver cirrhosis. Various treatment modalities are in use for treatment of Porto Systemic Encephalopathy (PSE).
Tanveer Hussain   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy